Table 2. Summary statistics of the top 20 KEGG integrated pathways ranked by the ratio between no. of miRNAs and no. of genes.
| Pathway name | No. of genes | No. of miRNAs + genes |  |
|---|---|---|---|
| Bladder cancer | 29 | 127 | 4.3 |
| Viral carcinogenesis | 6 | 26 | 4.3 |
| Dorso-ventral axis formation | 12 | 42 | 3.5 |
| Rheumatoid arthritis | 19 | 65 | 3.4 |
| Malaria | 11 | 35 | 3.1 |
| Glioma | 65 | 189 | 2.9 |
| Thyroid cancer | 28 | 80 | 2.8 |
| Melanoma | 69 | 196 | 2.8 |
| Colorectal cancer | 49 | 138 | 2.8 |
| Chronic myeloid leukemia | 73 | 204 | 2.7 |
| Endometrial cancer | 45 | 124 | 2.7 |
| Pancreatic cancer | 69 | 189 | 2.7 |
| p53 signaling pathway | 68 | 181 | 2.6 |
| Non-small cell lung cancer | 52 | 138 | 2.6 |
| Prostate cancer | 87 | 230 | 2.6 |
| Renal cell carcinoma | 60 | 145 | 2.4 |
| Acute myeloid leukemia | 57 | 133 | 2.3 |
| ErbB signaling pathway | 88 | 197 | 2.2 |
| Small cell lung cancer | 83 | 181 | 2.1 |
| VEGF signaling pathway | 67 | 146 | 2.1 |